Cellular interactions in the generation of cytolytic T lymphocyte responses. Analysis of the helper T cell pathway

European Journal of Immunology
O WeinbergerS J Burakoff

Abstract

Murine splenic lymphocytes exhibit a requirement for helper T cells for the induction of a cytolytic T lymphocyte response to suboptimal doses of allogeneic cells, membranes from allogeneic cells, or purified H-2 antigen in liposomes. The conditions where a requirement for help is apparent are the same conditions where a dependence on splenic adherent cells (SAC) has been demonstrated (Weinberger, O. et al., PROC. Natl. Acad, Sci, USA 1980. 77: 6091). Help can be provided in the form of primed, radioresistant, Ly-1+ spleen or lymph node cells or helper factor (interleukin 2, IL-2). A factor generated from phytohemagglutinin-stimulated human lymphocytes, when added to culture in the presence of antigen, bypassed the requirement for Ia+ SAC and helper cells. IL-2 reconstituted the response to H-2K(k) in liposomes in cultures depleted of SAC, strongly suggesting that the helper cell must see antigen re-expressed by an antigen-presenting cell, whereas the prekiller does not. IL-2 could be generated by culturing Ly-1+ murine spleen cells with H-2K(k) pulsed on SAC.

References

Dec 1, 1978·The Journal of Experimental Medicine·L L Baum, L M Pilarski
Apr 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·K Rulon, D W Talmage
Feb 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·S J BurakoffB Benacerrah
Oct 1, 1973·European Journal of Immunology·M H JuliusL A Herzenberg
Apr 1, 1980·The Journal of Experimental Medicine·A L Glasebrook, F W Fitch
Oct 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·O WeinbergerS J Burakoff

❮ Previous
Next ❯

Citations

Jan 1, 1994·Immunology Today·D A Shoskes, K J Wood
Jun 1, 1982·The Journal of Experimental Medicine·D H Raulet, M J Bevan
Feb 1, 1983·The Journal of Experimental Medicine·R M SteinmanM C Nussenzweig
Apr 1, 1983·The Journal of Experimental Medicine·J M AustynM A Palladino
Nov 27, 1982·Lancet·A Berken
Oct 1, 1987·Diabetes/metabolism Reviews·A NajiC F Barker
Jan 1, 1996·International Reviews of Immunology·J A Bradley
Jul 11, 2006·Immunological Reviews·Matthew F MescherZhengguo Xiao
Jan 1, 1981·Journal of Supramolecular Structure and Cellular Biochemistry·S H Herrmann, M F Mescher
May 1, 1986·European Journal of Immunology·R A SherwoodL S Rayfield

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.